Cleared Traditional

FX CorAL 60, FX CorAL 80, FX CorAL 100, FX CorAL 120, FX CorAL 600, FX CorAL 800, FX CorAL 1000

K220721 · Fresenius Medical Care Renal Therapies Group, LLC · Gastroenterology & Urology

May 2023

Decision

423d

Days

Class 2

Risk

About This 510(k) Submission

K220721 is an FDA 510(k) clearance for the FX CorAL 60, FX CorAL 80, FX CorAL 100, FX CorAL 120, FX CorAL 600, FX CorAL 800, FX CorAL 1000, a Dialyzer, High Permeability With Or Without Sealed Dialysate System (Class II — Special Controls, product code KDI), submitted by Fresenius Medical Care Renal Therapies Group, LLC (Waltham, US). The FDA issued a Cleared decision on May 11, 2023, 423 days after receiving the submission on March 14, 2022. This device falls under the Gastroenterology & Urology review panel. Regulated under 21 CFR 876.5860.

Submission Details

510(k) Number	K220721 FDA.gov
FDA Decision	Cleared SESE
Date Received	March 14, 2022
Decision Date	May 11, 2023
Days to Decision	423 days
Submission Type	Traditional
Review Panel	Gastroenterology & Urology (GU)
Summary	Summary PDF

Device Classification

Product Code	KDI — Dialyzer, High Permeability With Or Without Sealed Dialysate System
Device Class	Class II — Special Controls
CFR Regulation	21 CFR 876.5860